Skip to main content
. 2014 Aug 28;9(8):e105638. doi: 10.1371/journal.pone.0105638

Figure 1. Study flow diagram.

Figure 1

PBO, placebo; QD, once daily; CANA, canagliflozin; BID, twice daily. *Safety analysis set.